Apoptotic Colitis in a Liver Transplant Recipient: A Case of Solid Organ Transplant-Associated Graft-Versus-Host Disease
Jong Woo Yoo, Amira Hamed, Ying‐Hsia Chu, Ismail Elbaz Younes et autres
0 citationsCureus
Punita Grover
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
57Publications signalées
1072Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
COVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesSalivary Gland Tumors Diagnosis and TreatmentCAR-T cell therapy researchHead and Neck Cancer Studies
Publications récentes
Clinical Impact of Reduced-Dose Levofloxacin Pre-Engraftment Bacterial Prophylaxis In 3093 Allogeneic and 1719 Autologous Adult and Pediatric HCT Recipients at a Single Institution
Jo‐Anne H. Young, Shannon Lopez, James Westholder, Qing Cao et autres
0 citationsTransplantation and Cellular Therapy
Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma
Glenn J. Hanna, Olga Zamulko, Punita Grover, Douglas R. Adkins et autres
0 citationsJAMA Otolaryngology–Head & Neck Surgery
Targeting Aurora kinase A to prevent GVHD and relapse after myeloablative allogeneic hematopoietic cell transplantation
Shernan G. Holtan, Punita Grover, Kelly Walton, Najla El Jurdi et autres
0 citationsBlood Advances
COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium
Alaina J. Brown, Chih-Yuan Hsu, Aleenah Mohsin, Lauren S. Prescott et autres
0 citationsJCO oncology advances.
Coronary artery calcification and its effect on cardiac events in patients undergoing allogeneic stem cell transplantation using nonmyeloablative conditioning
Christopher Graham, Roy L. Kao, Qing Cao, Cameron McDonald-Hyman et autres
0 citationsBlood
Allogeneic hematopoietic stem cell transplantation for hematological malignancies using nonmyeloablative fludarabine, cyclophosphamide, 200 centigray total body irradiation, and post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil for graft-versus-host disease prophylaxis is associated with low non-relapse mortality.
Christopher Graham, Roy L. Kao, Qing Cao, Punita Grover et autres
0 citationsBlood
Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world
Aaron C. Logan, Fevzi Yalniz, Amy Zhang, Katharine Miller et autres
2 citationsBlood
Gtb-3650 (anti-CD16/IL-15/anti-CD33) tri-specific killer engager (TriKE®) for the treatment of high risk myelodysplastic syndromes (MDS) and refractory/relapsed (R/R) Acute Myeloid Leukemia (AML) (NCT06594445)
Mark Juckett, Christopher Graham, Punita Grover, Joseph Norton et autres
1 citationBlood
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Christopher McNair, Vadim S. Koshkin, Maryam B. Lustberg, Douglas B. Johnson et autres
0 citationsCarolina Digital Repository (University of North Carolina at Chapel Hill)
A Risk Adaptive Approach at Reduced Intensity Conditioning (RIC) and Transplantation of HLA-Haploidentical Hematopoietic Cells Using Fludarabine, Melphalan, Cyclophosphamide, and Total Body Irradiation (Flu/Mel/Cy/TBI) for Elderly or Infirm.
Christopher Graham, Qing Cao, Joseph Maakaron, Roy L. Kao et autres
0 citationsTransplantation and Cellular Therapy
High Incidence of Chronic Graft-Versus-Host Disease (cGVHD) with Post-Transplant Cyclophosphamide/Sirolimus/Mycophenolate (PTCy/Siro/MMF) Compared to Ptcy/Tacrolimus(Tac)/MMF Prophylaxis in Patients Undergoing Myeloablative Allogeneic Stem Cell Transplant (alloHCT)
Julia Meyer, Punita Grover, Qing Cao, Najla El Jurdi et autres
0 citationsTransplantation and Cellular Therapy
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.